The Journal of Pain
Volume 10, Issue 11 , Pages 1161-1169 , November 2009

Role of NFκB in an Animal Model of Complex Regional Pain Syndrome–type I (CRPS-I)

  • Marissa de Mos

      Affiliations

    • Pharmacoepidemiology Unit, Department of Medical Informatics & Epidemiology and Biostatistics, Erasmus Medical Center, Rotterdam, the Netherlands
    • Corresponding Author InformationAddress reprint requests to Dr. Marissa de Mos, Department of Medical Informatics, room 2157, Erasmus Medical Center, Dr. Molewaterplein 50, 3015 GE Rotterdam, The Netherlands.
    • ,
  • André Laferrière

      Affiliations

    • Department of Anesthesia, McGill University, Montréal, Quebec, Canada
    • ,
  • Magali Millecamps

      Affiliations

    • Department of Anesthesia, McGill University, Montréal, Quebec, Canada
    • Alan Edwards Center for Research on Pain, McGill University, Montréal, Quebec, Canada
    • ,
  • Mercedes Pilkington

      Affiliations

    • Psychology, McGill University, Montréal, Quebec, Canada
    • ,
  • Miriam C.J.M. Sturkenboom

      Affiliations

    • Pharmacoepidemiology Unit, Department of Medical Informatics & Epidemiology and Biostatistics, Erasmus Medical Center, Rotterdam, the Netherlands
    • ,
  • Frank J.P.M. Huygen

      Affiliations

    • Department of Anesthesiology, Erasmus Medical Center, Rotterdam, the Netherlands
    • ,
  • Terence J. Coderre

      Affiliations

    • Department of Anesthesia, McGill University, Montréal, Quebec, Canada
    • Alan Edwards Center for Research on Pain, McGill University, Montréal, Quebec, Canada
    • Psychology, McGill University, Montréal, Quebec, Canada
    • Neurology and Neurosurgery, McGill University, Montréal, Quebec, Canada
    • McGill University Health Care Research Institute, Montréal, Quebec, Canada

Received 8 October 2008 ,Revised 10 March 2009 ,Accepted 19 April 2009.

References 

  1. Alexander GM, van Rijn MA, van Hilten JJ, Perreault MJ, Schwartzman RJ. Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain. 2005;116(3):213–219
  2. Atreya I, Atreya R, Neurath MF. NF-kappaB in inflammatory bowel disease. J Intern Med. 2008;263:591–596
  3. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066–1071
  4. Birklein F, Schmelz M, Schifter S, Weber M. The important role of neuropeptides in complex regional pain syndrome. Neurology. 2001;57:2179–2184
  5. Birklein F, Weber M, Ernst M, Riedl B, Neundorfer B, Handwerker HO. Experimental tissue acidosis leads to increased pain in complex regional pain syndrome (CRPS). Pain. 2000;87:227–234
  6. Birrell MA, Hardaker E, Wong S, McCluskie K, Catley M, De Alba J, et al. Ikappa-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma. Am J Respir Crit Care Med. 2005;172:962–971
  7. Blair SJ, Chinthagada M, Hoppenstehdt D, Kijowski R, Fareed J. Role of neuropeptides in pathogenesis of reflex sympathetic dystrophy. Acta Orthop Belg. 1998;64:448–451
  8. Blaisdell FW. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: A review. Cardiovasc Surg. 2002;10:620–630
  9. Boone DL, Lee EG, Libby S, Gibson PJ, Chien M, Chan F, et al. Recent advances in understanding NF-kappaB regulation. Inflamm Bowel Dis. 2002;8:201–212
  10. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254
  11. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53:55–63
  12. Chen F, Castranova V, Shi X, Demers LM. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem. 1999;45:7–17
  13. Choi Y, Yoon YW, Na HS, Kim SH, Chung JM. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain. 1994;59:369–376
  14. Coderre TJ, Xanthos DN, Francis L, Bennett GJ. Chronic post-ischemia pain (CPIP): A novel animal model of complex regional pain syndrome-type I (CRPS-I; reflex sympathetic dystrophy) produced by prolonged hindpaw ischemia and reperfusion in the rat. Pain. 2004;112:94–105
  15. Cuzzocrea S, Chatterjee PK, Mazzon E, Dugo L, Serraino I, Britti D, et al. Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation. Br J Pharmacol. 2002;135:496–510
  16. Frangogiannis NG. Chemokines in ischemia and reperfusion. Thromb Haemost. 2007;97:738–747
  17. Gibbs GF, Drummond PD, Finch PM, Phillips JK. Unravelling the Pathophysiology of Complex Regional Pain Syndrome: Focus on sympathetically maintained pain. Clin Exp Pharmacol Physiol. 2008;35:717–724
  18. Gradl G, Finke B, Schattner S, Gierer P, Mittlmeier T, Vollmar B. Continuous intra-arterial application of substance P induces signs and symptoms of experimental complex regional pain syndrome (CRPS) such as edema, inflammation and mechanical pain but no thermal pain. Neuroscience. 2007;148:757–765
  19. Guo TZ, Wei T, Kingery WS. Glucocorticoid inhibition of vascular abnormalities in a tibia fracture rat model of complex regional pain syndrome type I. Pain. 2006;121:158–167
  20. Hattori Y, Hattori S, Sato N, Kasai K. High-glucose-induced nuclear factor kappaB activation in vascular smooth muscle cells. Cardiovasc Res. 2000;46:188–197
  21. Hettne KM, de Mos M, de Bruijn AG, Weeber M, Boyer S, van Mulligen EM, et al. Applied information retrieval and multidisciplinary research: New mechanistic hypotheses in Complex Regional Pain Syndrome. J Biomed Discov Collab. 2007;2:2
  22. Ho E, Chen G, Bray TM. Supplementation of N-acetylcysteine inhibits NFkappaB activation and protects against alloxan-induced diabetes in CD-1 mice. Faseb J. 1999;13:1845–1854
  23. Huygen FJ, De Bruijn AG, De Bruin MT, Groeneweg JG, Klein J, Zijlstra FJ. Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm. 2002;11:47–51
  24. Huygen FJ, Ramdhani N, van Toorenenbergen A, Klein J, Zijlstra FJ. Mast cells are involved in inflammatory reactions during complex regional pain syndrome type 1. Immunol Lett. 2004;91:147–154
  25. Inoue G, Ochiai N, Ohtori S, Nakagawa K, Gemba T, Doya H, et al. Injection of nuclear factor-kappa B decoy into the sciatic nerve suppresses mechanical allodynia and thermal hyperalgesia in a rat inflammatory pain model. Spine. 2006;31:2904–2908
  26. Jongeneel CV. Regulation of the TNF alpha gene. Prog Clin Biol Res. 1994;388:367–381
  27. Kalita J, Vajpayee A, Misra UK. Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: A randomized controlled trial. Qjm. 2006;99:89–95
  28. Kingery WS, Davies MF, Clark JD. A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II. Pain. 2003;104:75–84
  29. Koban M, Leis S, Schultze-Mosgau S, Birklein F. Tissue hypoxia in complex regional pain syndrome. Pain. 2003;104:149–157
  30. Kurvers H, Daemen M, Slaaf D, Stassen F, van den Wildenberg F, Kitslaar P, et al. Partial peripheral neuropathy and denervation induced adrenoceptor supersensitivity. Functional studies in an experimental model. Acta Orthop Belg. 1998;64:64–70
  31. Laughlin TM, Bethea JR, Yezierski RP, Wilcox GL. Cytokine involvement in dynorphin-induced allodynia. Pain. 2000;84:159–167
  32. Ledeboer A, Gamanos M, Lai W, Martin D, Maier SF, Watkins LR, et al. Involvement of spinal cord nuclear factor kappaB activation in rat models of proinflammatory cytokine-mediated pain facilitation. Eur J Neurosci. 2005;22:1977–1986
  33. Lee KM, Kang BS, Lee HL, Son SJ, Hwang SH, Kim DS, et al. Spinal NF-kB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity. Eur J Neurosci. 2004;19:3375–3381
  34. Leis S, Weber M, Isselmann A, Schmelz M, Birklein F. Substance-P-induced protein extravasation is bilaterally increased in complex regional pain syndrome. Exp Neurol. 2003;183:197–204
  35. Li W, Hou L, Hua Z, Wang X. Interleukin-1beta induces beta-calcitonin gene-related peptide secretion in human type II alveolar epithelial cells. Faseb J. 2004;18:1603–1605
  36. Lieb K, Fiebich BL, Berger M, Bauer J, Schulze-Osthoff K. The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. J Immunol. 1997;159:4952–4958
  37. Lille ST, Lefler SR, Mowlavi A, Suchy H, Boyle EM, Farr AL, et al. Inhibition of the initial wave of NF-kappaB activity in rat muscle reduces ischemia/reperfusion injury. Muscle Nerve. 2001;24:534–541
  38. Matsui N, Kasajima K, Hada M, Nagata T, Senga N, Yasui Y, et al. Inhibiton of NF-kappaB activation during ischemia reduces hepatic ischemia/reperfusion injury in rats. J Toxicol Sci. 2005;30:103–110
  39. Mattson MP, Meffert MK. Roles for NF-κB in nerve cell survival, plasticity and disease. Cell Death Differ. 2006;13:852–860
  40. Mestre C, Pelissier T, Fialip J, Wilcox G, Eschalier A. A method to perform direct transcutaneous intrathecal injection in rats. J Pharmacol Toxicol Methods. 1994;32:197–200
  41. Millecamps M, Coderre TJ. Rats with chronic post-ischemia pain exhibit an analgesic sensitivity profile similar to human patients with complex regional pain syndrome - type I. Eur J Pharmacol. 2008;583:97–102
  42. Nurmi A, Lindsberg PJ, Koistinaho M, Zhang W, Juettler E, Karjalainen-Lindsberg ML, et al. Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke. 2004;35:987–991
  43. Perez RS, Zuurmond WW, Bezemer PD, Kuik DJ, van Loenen AC, de Lange JJ, et al. The treatment of complex regional pain syndrome type I with free radical scavengers: A randomized controlled study. Pain. 2003;102:297–307
  44. Pollock G, Pennypacker KR, Memet S, Israel A, Saporta S. Activation of NF-kappaB in the mouse spinal cord following sciatic nerve transection. Exp Brain Res. 2005;165:470–477
  45. Richardson PG, Sonneveld P, Schuster MW, Irwin D, Stadtmauer EA, Facon T, et al. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med. 2005;352:2487–2498
  46. Roman-Blas JA, Jimenez SA. NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage. 2006;14:839–848
  47. Sakaue G, Shimaoka M, Fukuoka T, Hiroi T, Inoue T, Hashimoto N, et al. NF-kappa B decoy suppresses cytokine expression and thermal hyperalgesia in a rat neuropathic pain model. Neuroreport. 2001;12:2079–2084
  48. Sehgal PB. Regulation of IL6 gene expression. Res Immunol. 1992;143:724–734
  49. Stansfield WE, Moss NC, Willis MS, Tang R, Selzman CH. Proteasome inhibition attenuates infarct size and preserves cardiac function in a murine model of myocardial ischemia-reperfusion injury. Ann Thorac Surg. 2007;84:120–125
  50. Sun T, Song WG, Fu ZJ, Liu ZH, Liu YM, Yao SL. Alleviation of neuropathic pain by intrathecal injection of antisense oligonucleotides to p65 subunit of NF-kappaB. Br J Anaesth. 2006;97:553–558
  51. Tegeder I, Niederberger E, Schmidt R, Kunz S, Guhring H, Ritzeler O, et al. Specific Inhibition of IkappaB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. J Neurosci. 2004;24:1637–1645
  52. Uwe S. Anti-inflammatory interventions of NF-kappaB signaling: Potential applications and risks. Biochem Pharmacol. 2008;75:1567–1579
  53. van der Laan L, ter Laak HJ, Gabreels-Festen A, Gabreels F, Goris RJ. Complex regional pain syndrome type I (RSD): Pathology of skeletal muscle and peripheral nerve. Neurology. 1998;51:20–25
  54. Watkins LR, Maier SF. Beyond neurons: Evidence that immune and glial cells contribute to pathological pain states. Physiol Rev. 2002;82:981–1011
  55. Xanthos DN, Coderre TJ. Sympathetic vasoconstrictor antagonism and vasodilatation relieve mechanical allodynia in rats with chronic postischemia pain. J Pain. 2008;9:423–433

 Supported by the Dutch CRPS patient association (Stichting Esperance), the Canadian Institutes of Health Research, and the Louise and Allan Edwards Foundation.

PII: S1526-5900(09)00504-5

doi: 10.1016/j.jpain.2009.04.012

The Journal of Pain
Volume 10, Issue 11 , Pages 1161-1169 , November 2009

Article Tools

* Image Usage & Resolution